Creganna-Tactx Medical CEO Helen Ryan is preparing to pass the torch after 8 years in the corner office, with Abbott (NYSE:ABT) executive Robert "Chip" Hance slated to take the helm in September.
Hance worked at the Illinois-based device giant for 23 years, most recently as head of the vascular division where he led the roll-out of the Xience stent in the U.S., Japan and China.
"I would like to take this opportunity to thank Helen for the leadership and strong customer focus she has shown in her role as chief executive," said chairman Scott Ward in prepared remarks. "Thanks to Helen’s commitment and vision, Creganna-Tactx Medical has a strong and solid future as a leader in delivering medical technology solutions."
Ryan, who spent her earlier career in R&D roles at Covidien (NYSE:COV) and Medtronic (NYSE:MDT), will stay on until the end of the summer. Creganna-Tactx did not state the reason for the swap.
Imris Inc. COO steps up and CEO moves over
Imris Inc. chairman & CEO David Graves is cutting "executive" out of his title, limiting his role to board chairman and making room for the company’s current operations chief, Jay Miller, to take over the corner office. Miller previously worked as CEO of Zonare Inc. and Vital Images.
Read more
Canon names a new Prez of its Virtual Imaging subsidiary
Canon pulled the new president of its Virtual Imaging subsidiary from in-house. Tsuneo Imai will now head the division in addition to his current role as director of the healthcare solutions division. Former president Chris Duca will move over to a support role as a technical advisor to Imai. Canon acquired Virtual Imaging 4 years ago to bolster its x-ray business.
Read more
St. Jude board member returns to the table
St. Jude Medical (NYSE:STJ) handed former employee Stefan Widensohler a seat on the board of directors. Widensohler is currently the CEO of KRAUTH Medical Group, a medical distribution company in Europe. He worked for the medical device giant from 2001 to 2010 as director.
"We are very pleased to have Stefan Widensohler return to the St. Jude Medical board of directors," said CEO Daniel Starks in prepared remarks.
Read more
Align Technology brings a former Novartis exec on board
Align Technology (NSDQ:ALGN) appointed Andrea Saia to its board of directors, where she will sit on the audit committee. Saia is also a board member at Coca-Cola and formerly worked in executive roles at Novartis AG (NYSE:NVS) subsidiaries Alcon and CibaVision.
Read more
